Experts say we’re in a golden age for treating chronic kidney disease, with new drugs like Ozempic yielding major results.

To address knowledge gaps, investigators conducted a meta-analysis of more than 70,000 patients in 10 trials of SGLT2 inhibitors vs placebo to determine the relative risks of CKD progression across ...

Medications and extra fluid infusions can help protect your kidneys from damage during chemotherapy. More than one million people receive chemotherapy or radiation treatments for their cancer each ...

Elevated creatinine signals kidney stress, but natural strategies can help. Focus on a diet rich in fruits and vegetables, ...

A personalised, moderately restricted low-protein diet is feasible in advanced CKD and is linked to a slower decline in ...

The results of two large-scale studies demonstrate that sodium-glucose co-transporter 2 (SGLT2) inhibitors significantly ...

The FDA has approved MediBeacon®'s TGFR system for noninvasive kidney function assessment, targeting both normal and impaired renal patients. INNOVATE Corp. announced the FDA approval of the ...

The Liberation From Acute Dialysis (LIBERATE-D) randomized clinical trial tested the value of a conservative vs conventional hemodialysis strategy on recovery of kidney function in stable patients ...

Transdermal GFR System (TGFR) is a first-in-kind product for point of care assessment of kidney function in patients with normal or impaired renal function The transdermal GFR (tGFR) methodology has ...

The current kidney transplant waitlisting criterion is based on a single measurement of kidney function (estimated glomerular ...

Transdermal GFR System (TGFR) is a first-in-kind product for point of care assessment of kidney function in patients with normal or impaired renal function. The transdermal GFR (tGFR) methodology has ...